ClinicalTrials.gg
RecruitingNCT07939503Updated Nov 16, 2026

Web-Based Training for Pain Management

An interventional study of Web-Based Pain Management Education Program in Pain Management, sponsored by Lokman Hekim University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 2 Months to 13 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-16.

Sponsored by Lokman Hekim University · Not applicable, Interventional, and Supportive care

Updated Nov 16, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
128
Allocation
Non-randomized
Ages
2 Months to 13 Years
Sex
All
01

Study summary

Inadequate management of pain during vaccination may lead to negative vaccination experiences, needle fear, and future vaccine non-adherence in children. This study aims to develop a web-based pain management education program for nurses/midwives and parents to reduce vaccination-related pain in children and evaluate its effectiveness. The study will be conducted using a quasi-experimental pretest-posttest design with a non-randomized control group in two Family Health Centers. Pain will be assessed using the FLACC Pain Scale for children aged 0-3 years and the Wong-Baker FACES Pain Rating Scale for children aged 3 years and older. Pain management practices will be evaluated using an observation form. The information quality of the program will be assessed using DISCERN, and its usability will be evaluated using the System Usability Scale (SUS). Data will be analyzed using appropriate parametric and non-parametric tests. The intervention effect will be evaluated by examining the group-by-time interaction. Statistical significance will be set at p\<0.05.

02

Conditions studied

  • Pain Management
03

In context

Lead sponsor

Lokman Hekim University is the lead sponsor of 44 studies on the registry; 18 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
2 Months to 13 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Nurses/Midwives:

  • Nurses or midwives who administer childhood vaccinations.
  • Nurses or midwives who voluntarily agree to participate in the study.

Parents:

  • Parents of children aged 2 months to 13 years.
  • Parents whose children are scheduled to receive routine vaccinations.
  • Parents who are able to read Turkish.

Exclusion criteria

Exclusion Criteria:

Children:

  • Children with neurological disorders affecting pain perception.
  • Children who have received analgesic medications.
  • Children who are receiving antibiotic treatment.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
128 participants (estimated)

Study arms

  • Experimental
    Web Based Training Group

    Behavioral: Web-Based Pain Management Education Program

  • No intervention
    Control Group

Interventions

  • BehavioralWeb-Based Pain Management Education Program

    A web-based, evidence-based pain management education program will be provided separately to nurses/midwives and parents to reduce vaccination-related pain in children. The program includes educational modules consisting of text, visual materials, and videos. The content covers childhood pain, age-specific pain assessment, and evidence-based pharmacological and non-pharmacological pain management approaches. Nurses/midwives will complete approximately 90 minutes of education, while parents will complete approximately 40 minutes of education. Nurses/midwives will complete the program before the post-intervention observation period. Parents will receive the program link and will be asked to complete all modules before vaccination. Module completion will be monitored through the web-based platform.

06

What researchers measure

Primary outcomes

  1. Evidence-Based Pain Management Practices by Nurses/Midwives

    Evidence-based pharmacological and non-pharmacological pain management practices performed by nurses/midwives before, during, and after childhood vaccination will be assessed using the Nurse/Midwife Observation Form. Each practice will be scored as performed (1) or not performed (0). Higher total scores indicate more frequent use of pain management practices.

    Time frame: At baseline and during the post-intervention observation period, before, during, and immediately after vaccination.

  2. Evidence-Based Pain Management Practices by Parents

    Evidence-based pharmacological and non-pharmacological pain management practices performed by parents before, during, and after childhood vaccination will be assessed using the Parent Observation Form. Each practice will be scored as performed (1) or not performed (0). Higher total scores indicate more frequent use of pain management practices.

    Time frame: At baseline and during the post-intervention observation period, before, during, and immediately after vaccination.

  3. Vaccination-Related Pain Scores in Children Aged 0-Under 3 Years

    Vaccination-related pain will be assessed using the FLACC (Face, Legs, Activity, Cry, Consolability) Pain Scale. Scores range from 0 to 10, with higher scores indicating greater pain intensity.

    Time frame: after vaccination implementation

  4. Vaccination-Related Pain Scores in Children Aged 3 Years and Older

    Vaccination-related pain will be assessed using the Wong-Baker FACES Pain Rating Scale. Scores range from 0 to 10, with higher scores indicating greater pain intensity.

    Time frame: after vaccination implementation

Secondary outcomes

  1. Quality and Reliability of the Web-Based Pain Management Education Program

    The quality and reliability of the web-based pain management education program will be evaluated by 5-7 academic experts using the DISCERN instrument. The instrument consists of 16 items and total scores range from 16 to 80. Higher scores indicate better information quality and reliability.

    Time frame: After development of the web-based pain management education program and before its implementation

  2. Usability of the Web-Based Pain Management Education Program

    The usability of the web-based pain management education program will be evaluated using the 10-item System Usability Scale (SUS) by nurses/midwives and parents. Total scores range from 0 to 100, with higher scores indicating better usability. Scores of 65 or above will be considered acceptable usability.

    Time frame: Immediately after completion of the web-based pain management education program

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Nov 2026 (actual). Primary completion is estimated for Sep 2027, 10 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 4, 2026
First posted
Nov 16, 2026
StartActual
Nov 2, 2026
Primary completionEst.
Sep 30, 2027
CompletionEst.
Sep 30, 2027
Last update
Nov 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 16, 2026
Show all 1 update
  1. Nov 16, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07939503
Lead sponsor
Lokman Hekim University
Responsible party
Mujde CALIKUSU INCEKAR (Associate Profesor, Lokman Hekim University) — Principal investigator
First posted
Nov 16, 2026
Start date
Nov 2, 2026
Primary completion
Sep 30, 2027 (estimated)
Completion
Sep 30, 2027 (estimated)
Last update
Nov 16, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion